PMDA drug package insert
リスペリドン錠0.5mg「アメル」
PMDA Prescription drug · 共和薬品工業株式会社 · package insert Feb 14, 2025
Key facts
| Brand names | リスペリドン錠0.5mg「アメル」, リスペリドン錠1mg「アメル」, リスペリドン錠2mg「アメル」, リスペリドン錠3mg「アメル」, リスペリドン細粒1％「アメル」 |
|---|---|
| Nonproprietary names | リスペリドン |
| Companies | 製造販売元／共和薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗精神病剤 |
| Therapeutic category codes | 871179 |
| YJ codes | 1179038F4057, 1179038F1074, 1179038F2070, 1179038F3034, 1179038C1078 |
| Approval numbers | 22200AMX00808, 21900AMZ00045, 21900AMZ00046, 21900AMZ00047, 21900AMZ00048 |
| Package insert edition | 第4版 |
| Package insert date | Feb 14, 2025 |
| PMDA document key | 672173_1179038C1078_2 |
| PMDA company code | 672173 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: